The Global Health Primer connects the capable innovators that drive research and development for new drugs, vaccines, and diagnostics to the neglected tropical diseases where innovation is desperately needed. In the 2011 update, we have significantly expanded the Primer to showcase more opportunities for those who want to make an impact on global health. Some highlights include: 

• Creation of drug target and vaccine technology profiles in addition to the neglected disease profiles. These profiles group products in development by drug target classes and vaccine technologies that may span multiple diseases.
• Expansion of each disease profile to include drug target and vaccine technology analysis that spotlights opportunities for application to neglected tropical diseases.
• Greater analysis of strengths, weaknesses, opportunities, and risks for products currently in development for neglected tropical diseases, as well as information on development tools that are available to facilitate new product development.

To learn more, please select one of the choices:

Watch a short demo of the Global Health Primer here:

If you missed the Global Health Primer webinar on March 8, 2011, you can watch it here.

The Global Health Primer is continuously updated throughout the year. To learn how you can get involved in neglected disease drug, vaccine or diagnostic research and development, or to provide updates, changes, or corrections to the Global Health Primer website, please view our FAQs or contact us at globalhealthprimer@bvgh.org.

Last updated: January 6, 2012